The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.80
Ask: 1.90
Change: 0.05 (2.78%)
Spread: 0.10 (5.556%)
Open: 1.825
High: 1.85
Low: 1.825
Prev. Close: 1.80
AEX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re: Rights Issue

18 Jul 2007 15:51

Aminex PLC18 July 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART OR IN WHOLE IN OR INTO THEUNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN FOR IMMEDIATE RELEASE 18 JULY 2007 Aminex PLC ("Aminex" or "the Company") Further re: Rights Issue Placing of 2,705,476 New Ordinary Shares not taken up in the Rights Issue Further to the announcement issued on 16 July 2007 that Aminex had receivedvalid acceptances in respect of 14,465,371 New Ordinary Shares, representingapproximately 51.4 per cent. of the New Ordinary Shares offered to QualifyingShareholders under the 1 for 6 Rights Issue, the Company announces that Davy hasprocured subscribers for 2,705,476 New Ordinary Shares (including theentitlement of overseas shareholders and fractional entitlements) which were notvalidly taken up in the Rights Issue, at a price of Stg£0.21 per New OrdinaryShare. The remaining New Ordinary Shares available under the Rights Issue willnot be issued. Subscribers for Rights Issue Shares are entitled to 1 New Warrant for every 2Rights Issue Shares subscribed for so long as they are recorded as theregistered holder of those Rights Issue Shares at Admission on 2 August 2007(the date on which the Rights Issue Shares and associated New Warrants areexpected to be credited to CREST stock accounts). The Company has raised gross proceeds of US$29.27m from the Firm Placing and theRights Issue (including this Placing). Following completion of the Rights Issue, the Company has 242,031,747 OrdinaryShares in issue and 36,526,673 New Warrants in issue. There are no net proceeds from the sale of these New Ordinary Shares, afterdeduction of the Rights Issue Price of Stg£0.20 per share and relevant costs, tobe paid to those shareholders who have not taken up their Rights Issueentitlements. Definitions used in the Prospectus dated 23 May 2007 shall have the samemeanings when used in this announcement. For further information: Aminex PLCBrian Hall Tel: +44 (0) 20 7291 3100 DavyEugenee Mulhern / Fergal Meegan Tel: +353 (0) 1 679 6363 BridgewellAndrew Matharu Tel: + 44 (0) 20 7003 3105 Pelham Public RelationsArchie Berens Tel: +44 (0) 20 7743 6679 Davy Corporate Finance Limited and J&E Davy (collectively ''Davy'') (each ofwhich is regulated in Ireland by the Irish Financial Services RegulatoryAuthority) and Bridgewell Limited (''Bridgewell'') (which is regulated in the UKby the Financial Services Authority) are acting exclusively for Aminex inconnection with the requirements of the Irish Stock Exchange and the UK ListingAuthority and for no one else and will not be responsible to any other personfor providing the protection afforded to customers of Davy or Bridgewell nor forproviding advice in connection with this announcement. Participation in the Rights Issue is not and has not been available toshareholders resident in the United States, Australia, Canada, South Africa orJapan or any other jurisdiction where it would be unlawful to offerparticipation. This announcement does not constitute, or form part of, an offer of, or thesolicitation of any offer to subscribe for or buy, any of the Ordinary Shares orWarrants to be issued or sold in connection with the Placing and/or RightsIssue. Investors should not subscribe for or purchase any securities referred toin this announcement except on the basis of information in the Prospectuspublished by the Company on 23 May 2007 in connection with the Placing andRights Issue. The offer of the Ordinary Shares and Warrants in certain jurisdictions may berestricted by law and therefore potential investors should inform themselvesabout and observe any such restrictions. This announcement is not forpublication or distribution, directly or indirectly, in or into the UnitedStates. This announcement is for information only and does not constitute anoffer or invitation to acquire or dispose of Ordinary Shares or Warrants in theUnited States. The Placing and Rights Issue will not be an offer of securitiesfor sale in the United States. Securities may not be offered or sold in theUnited States absent registration or an exemption from registration. TheOrdinary Shares and Warrants have not been and will not be registered under theUS Securities Act of 1933, as amended ('the Securities Act'), or with anysecurities regulatory authority of any state or other jurisdiction of the UnitedStates, and may not be offered or sold in the United States, except pursuant toan exemption from, or in a transaction not subject to, the registrationrequirements of the Securities Act. There will be no public offering of OrdinaryShares or Warrants in Aminex in the United States. Past performance is no guide to future performance and persons needing adviceshould consult an independent financial adviser. The distribution of this announcement may be restricted by law. No action hasbeen taken that would permit the possession or distribution of this announcementin any jurisdiction where action for that purpose is required. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd May 20244:04 pmRNSNtorya Development Licence Granted
10th May 20247:00 amRNSUpdate on Ntorya to Madimba Pipeline
29th Apr 20247:01 amRNSFinal Results and Annual Report 2023
29th Apr 20247:00 amRNSFunding Facility agreed with Eclipse Investments
29th Feb 20247:00 amRNSRuvuma Seismic Update
10th Jan 20242:49 pmRNSRuvuma Gas Sales Agreement signed
31st Oct 20235:00 pmRNSKiliwani Operations Update
29th Sep 20237:00 amRNS2023 Half-Yearly Financial Report
1st Sep 20237:00 amRNSDirectorate Change
13th Jul 20234:26 pmRNSResult of AGM
12th Jul 20237:00 amRNSRuvuma Operations Update
20th Jun 20237:00 amRNSNotice of AGM
2nd Jun 20233:13 pmRNSDirector/PDMR Shareholding
26th May 20237:00 amRNSPublication of New Research
28th Apr 20236:13 pmRNSFinal Results and Annual Report 2022
2nd Mar 20237:00 amRNSStrategy/Company/Ops Update
6th Feb 202311:05 amRNSSecond Price Monitoring Extn
6th Feb 202311:00 amRNSPrice Monitoring Extension
6th Feb 20239:05 amRNSSecond Price Monitoring Extn
6th Feb 20239:00 amRNSPrice Monitoring Extension
28th Nov 202211:05 amRNSSecond Price Monitoring Extn
28th Nov 202211:00 amRNSPrice Monitoring Extension
28th Nov 20227:00 amRNSRuvuma Commercial Update
1st Nov 202211:05 amRNSSecond Price Monitoring Extn
1st Nov 202211:00 amRNSPrice Monitoring Extension
1st Nov 20229:05 amRNSSecond Price Monitoring Extn
1st Nov 20229:00 amRNSPrice Monitoring Extension
1st Nov 20227:23 amRNSRuvuma Operations Update
6th Oct 20224:41 pmRNSSecond Price Monitoring Extn
6th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNS2022 Half-Yearly Financial Report
1st Sep 202210:59 amRNSRuvuma PSA
1st Sep 20227:00 amRNSRuvuma Seismic and Commercial Update
18th Aug 20222:05 pmRNSSecond Price Monitoring Extn
18th Aug 20222:00 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Aug 20227:00 amRNSKiliwani Operations Update
1st Aug 20227:00 amRNSStrategy/Company/Ops Update
13th Jul 20224:23 pmRNSRuvuma PSA
6th Jun 20222:06 pmRNSSecond Price Monitoring Extn
6th Jun 20222:00 pmRNSPrice Monitoring Extension
1st Jun 20223:41 pmRNSTotal Voting Rights
26th May 20224:04 pmRNSResult of AGM
4th May 20227:00 amRNSNotice of AGM
11th Apr 20227:00 amRNSFinal Results and Annual Report 2021
8th Apr 20227:00 amRNSTanzania Operations Update
1st Apr 20224:41 pmRNSSecond Price Monitoring Extn
1st Apr 20224:36 pmRNSPrice Monitoring Extension
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.